Clinical Trial Update: Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers [Phase 2]

View source ↗

Summary

Phase II imaging study evaluating [18F]AV-45 (florbetapir) for amyloid imaging in patients with mild cognitive impairment and Alzheimer's disease, plus healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN